Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
10581 | 1051 | 41.1 | 85% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
11 | 3 | ATRIAL FIBRILLATION//CARDIAC & CARDIOVASCULAR SYSTEM//CATHETER ABLATION | 130936 |
691 | 2 | POTASSIUM CHANNELS//BK CHANNEL//RETIGABINE | 13105 |
10581 | 1 | RETIGABINE//FLUPIRTINE//KCNQ | 1051 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | RETIGABINE | authKW | 2519427 | 10% | 80% | 109 |
2 | FLUPIRTINE | authKW | 1850112 | 8% | 81% | 79 |
3 | KCNQ | authKW | 1820534 | 9% | 67% | 94 |
4 | M CURRENT | authKW | 1789654 | 11% | 56% | 111 |
5 | KCNQ2 | authKW | 1106465 | 4% | 81% | 47 |
6 | LINOPIRDINE | authKW | 920573 | 4% | 81% | 39 |
7 | KCNQ CHANNELS | authKW | 860781 | 4% | 74% | 40 |
8 | KV7 | authKW | 764830 | 4% | 71% | 37 |
9 | KV7 CHANNELS | authKW | 649263 | 3% | 72% | 31 |
10 | M CHANNEL | authKW | 585718 | 2% | 81% | 25 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Neurosciences | 3199 | 33% | 0% | 348 |
2 | Pharmacology & Pharmacy | 2198 | 28% | 0% | 295 |
3 | Clinical Neurology | 1137 | 16% | 0% | 163 |
4 | Physiology | 981 | 11% | 0% | 119 |
5 | Chemistry, Medicinal | 286 | 6% | 0% | 59 |
6 | Biochemistry & Molecular Biology | 25 | 9% | 0% | 96 |
7 | Cell Biology | 20 | 4% | 0% | 47 |
8 | Behavioral Sciences | 19 | 1% | 0% | 15 |
9 | Genetics & Heredity | 16 | 3% | 0% | 33 |
10 | Psychiatry | 13 | 2% | 0% | 26 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NEW LEADS BIOL | 145260 | 0% | 100% | 5 |
2 | ASTA MED GRP | 118623 | 1% | 58% | 7 |
3 | ION CHANNELS GRP | 92965 | 0% | 80% | 4 |
4 | ABT MED DEUT LAND | 87156 | 0% | 100% | 3 |
5 | CHILDREN NEUROL UNIT | 58104 | 0% | 100% | 2 |
6 | LEHRSTUHL BIOCHEM REZEPTORBIOCHEM 1 | 58104 | 0% | 100% | 2 |
7 | SECT EARLY TARGET PHARMACOL PHYSIOL | 58104 | 0% | 100% | 2 |
8 | PHARMACOL CELL PHYSIOL GRP | 51644 | 0% | 44% | 4 |
9 | WELLCOME MOL PHARMACOL | 42007 | 1% | 16% | 9 |
10 | CNRSUMR 6150 | 38735 | 0% | 67% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EPILEPSY RESEARCH | 4288 | 2% | 1% | 24 |
2 | JOURNAL OF NEUROSCIENCE | 3450 | 6% | 0% | 64 |
3 | EPILEPSIA | 3090 | 3% | 0% | 31 |
4 | JOURNAL OF GENERAL PHYSIOLOGY | 2510 | 2% | 1% | 17 |
5 | JOURNAL OF PHYSIOLOGY-LONDON | 2484 | 4% | 0% | 40 |
6 | BRITISH JOURNAL OF PHARMACOLOGY | 2073 | 3% | 0% | 36 |
7 | CHANNELS | 1379 | 0% | 1% | 5 |
8 | MOLECULAR PHARMACOLOGY | 1280 | 2% | 0% | 21 |
9 | POSTGRADUATE MEDICAL JOURNAL | 1090 | 2% | 0% | 17 |
10 | GIORNALE DI GERONTOLOGIA | 1036 | 0% | 4% | 1 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | RETIGABINE | 2519427 | 10% | 80% | 109 | Search RETIGABINE | Search RETIGABINE |
2 | FLUPIRTINE | 1850112 | 8% | 81% | 79 | Search FLUPIRTINE | Search FLUPIRTINE |
3 | KCNQ | 1820534 | 9% | 67% | 94 | Search KCNQ | Search KCNQ |
4 | M CURRENT | 1789654 | 11% | 56% | 111 | Search M+CURRENT | Search M+CURRENT |
5 | KCNQ2 | 1106465 | 4% | 81% | 47 | Search KCNQ2 | Search KCNQ2 |
6 | LINOPIRDINE | 920573 | 4% | 81% | 39 | Search LINOPIRDINE | Search LINOPIRDINE |
7 | KCNQ CHANNELS | 860781 | 4% | 74% | 40 | Search KCNQ+CHANNELS | Search KCNQ+CHANNELS |
8 | KV7 | 764830 | 4% | 71% | 37 | Search KV7 | Search KV7 |
9 | KV7 CHANNELS | 649263 | 3% | 72% | 31 | Search KV7+CHANNELS | Search KV7+CHANNELS |
10 | M CHANNEL | 585718 | 2% | 81% | 25 | Search M+CHANNEL | Search M+CHANNEL |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | MALJEVIC, S , LERCHE, H , (2014) POTASSIUM CHANNEL GENES AND BENIGN FAMILIAL NEONATAL EPILEPSY.GENETICS OF EPILEPSY. VOL. 213. ISSUE . P. 17 -53 | 103 | 67% | 13 |
2 | WICKENDEN, AD , MCNAUGHTON-SMITH, G , (2009) KV7 CHANNELS AS TARGETS FOR THE TREATMENT OF PAIN.CURRENT PHARMACEUTICAL DESIGN. VOL. 15. ISSUE 15. P. 1773-1798 | 82 | 90% | 29 |
3 | DALBY-BROWN, W , HANSEN, HH , KORSGAARD, MPG , MIRZA, N , OLESEN, SP , (2006) K(V)7 CHANNELS: FUNCTION, PHARMACOLOGY AND CHANNEL MODULATORS.CURRENT TOPICS IN MEDICINAL CHEMISTRY. VOL. 6. ISSUE 10. P. 999-1023 | 117 | 66% | 26 |
4 | BROWN, DA , PASSMORE, GM , (2009) NEURAL KCNQ (KV7) CHANNELS.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 156. ISSUE 8. P. 1185 -1195 | 60 | 80% | 231 |
5 | GREENE, DL , HOSHI, N , (2017) MODULATION OF KV7 CHANNELS AND EXCITABILITY IN THE BRAIN.CELLULAR AND MOLECULAR LIFE SCIENCES. VOL. 74. ISSUE 3. P. 495 -508 | 97 | 59% | 0 |
6 | MICELI, F , SOLDOVIERI, MV , MARTIRE, M , TAGLIALATELA, M , (2008) MOLECULAR PHARMACOLOGY AND THERAPEUTIC POTENTIAL OF NEURONAL KV7-MODULATING DRUGS.CURRENT OPINION IN PHARMACOLOGY. VOL. 8. ISSUE 1. P. 65 -74 | 67 | 89% | 64 |
7 | JEPPS, TA , OLESEN, SP , GREENWOOD, IA , (2013) ONE MAN'S SIDE EFFECT IS ANOTHER MAN'S THERAPEUTIC OPPORTUNITY: TARGETING KV7 CHANNELS IN SMOOTH MUSCLE DISORDERS.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 168. ISSUE 1. P. 19-27 | 63 | 85% | 14 |
8 | BARRESE, V , MICELI, F , SOLDOVIERI, MV , AMBROSINO, P , IANNOTTI, FA , CILIO, MR , TAGLIALATELA, M , (2010) NEURONAL POTASSIUM CHANNEL OPENERS IN THE MANAGEMENT OF EPILEPSY: ROLE AND POTENTIAL OF RETIGABINE.FRONTIERS IN PHARMACOLOGY. VOL. 2. ISSUE . P. 225 -236 | 69 | 81% | 1 |
9 | GRIBKOFF, VK , (2008) THE THERAPEUTIC POTENTIAL OF NEURONAL K(V)7 (KCNQ) CHANNEL MODULATORS: AN UPDATE.EXPERT OPINION ON THERAPEUTIC TARGETS. VOL. 12. ISSUE 5. P. 565 -581 | 79 | 64% | 27 |
10 | GUNTHORPE, MJ , LARGE, CH , SANKAR, R , (2012) THE MECHANISM OF ACTION OF RETIGABINE (EZOGABINE), A FIRST-IN-CLASS K+ CHANNEL OPENER FOR THE TREATMENT OF EPILEPSY.EPILEPSIA. VOL. 53. ISSUE 3. P. 412 -424 | 46 | 81% | 69 |
Classes with closest relation at Level 1 |